z-logo
open-access-imgOpen Access
Novel Expression of GABAA Receptors on Resistance Arteries That Modulate Myogenic Tone
Author(s) -
Peter D. Yim,
George Gallos,
Steven A. Lee-Kong,
William Dan,
Andrew Wu,
Dingbang Xu,
Dan E. Berkowitz,
Charles W. Emala
Publication year - 2020
Publication title -
journal of vascular research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.58
H-Index - 74
eISSN - 1423-0135
pISSN - 1018-1172
DOI - 10.1159/000505456
Subject(s) - gabaa receptor , myograph , receptor , biology , gabaa rho receptor , medicine , vascular smooth muscle , endocrinology , cerebral arteries , microbiology and biotechnology , neuroscience , endothelium , smooth muscle
The clinical administration of GABAergic medications leads to hypotension which has classically been attributed to the modulation of neuronal activity in the central and peripheral nervous systems. However, certain types of peripheral smooth muscle cells have been shown to express GABAA receptors, which modulate smooth muscle tone, by the activation of these chloride channels on smooth muscle cell plasma membranes. Limited prior studies demonstrate that non-human large-caliber capacitance blood vessels mounted on a wire myograph are responsive to GABAA ligands. We questioned whether GABAA receptors are expressed in human resistance arteries and whether they modulate myogenic tone. We demonstrate the novel expression of GABAA subunits on vascular smooth muscle from small-caliber human omental and mouse tail resistance arteries. We show that GABAA receptors modulate both plasma membrane potential and calcium responses in primary cultured cells from human resistance arteries. Lastly, we demonstrate functional physiologic modulation of myogenic tone via GABAA receptor activation in human and mouse arteries. Together, these studies demonstrate a previously unrecognized role for GABAA receptors in the modulation of myogenic tone in mouse and human resistance arteries.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here